NEW ORLEANS (AP) — The pharmaceutical companies behind the widely advertised blood thinner Xarelto reached a $775 million settlement in 25,000 lawsuits alleging patients were not adequately warned ...
LONDON (Reuters) - Bayer's patent covering its best-selling blood thinner Xarelto is invalid, London's High Court ruled on Friday in a blow to the German drugmaker. The company's blockbuster Xarelto ...
Photo: Alfred Sonsalla/Shutterstock.com [/caption] The first Xarelto bellwether trial in Philadelphia took a turn into political themes during closing arguments Friday, with attorneys making ...
Pune, April 18, 2022 (GLOBE NEWSWIRE) -- Global Xarelto Market research report 2022-2028 is a professional and in-depth study on the current state of the global Xarelto industry with a focus on the ...
The quality and depth of clinical trials of the blood-thinner Xarelto could be a key issue when the first trials over the drug begin in Philadelphia courtrooms. With the first trial of more than 800 ...
The very day that a national report is issued naming the Philadelphia County Court of Common Pleas as a “Judicial Hellhole” where civil lawsuits are handled unfairly against businesses, the first win ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback